GENE ONLINE|News &
Opinion
Blog

mRNA
Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel
2022-05-23
Scientists Jointly Urge FDA to Evaluate T-Cell Response in Review of COVID-19 Vaccines
2022-04-27
Moderna Shares Promising Preliminary Bivalent COVID-19 Booster Results
2022-04-20
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
Was Novavax’s Vaccine Rollout Smooth?
2022-03-16
Moderna Unveils Three New mRNA Vaccine Programs
2022-02-21
Bioplus Interphex 2021: CDMOs- The Manufacturing Hub for the Next Generation of Therapeutics
2021-11-30
Sanofi Bets on Baidu’s Algorithm to Develop mRNA-Based Therapeutics
2021-11-23
Moderna, AstraZeneca Tout Encouraging Trial Data for mRNA-Based Therapeutic in Cardiac Health
2021-11-16
Daiichi Sankyo to Launch mRNA COVID-19 Vaccine in 2022, Shionogi Presents Clinical Results of COVID-19 Oral Drug
2021-10-22
Sanofi Abandons mRNA-Based COVID-19 Vaccine Plan but Indian Biotechs March On
2021-09-28
COVID-19: Pfizer/BioNTech Say Their Vaccine is Safe and Protective in 5- to 11-Year-Olds
2021-09-20
Moderna Inks Deal with AbCellera to Develop Therapeutic Antibodies for mRNA Medicines
2021-09-15
China’s Sinopharm to Develop its First mRNA COVID-19 Vaccine
2021-09-07
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
1 2 3
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!